Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
about
Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.The role of glucagon-like peptide-1 receptor agonists in cardiovascular disease prevention in type 2 diabetes mellitus: evidence from the most recent clinical trials.Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes.Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials.SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors.Improving Postdischarge Outcomes in Acute Heart Failure
P2860
Q52673331-6C9B34FB-1B4E-4E3D-A978-F95E030EE1DDQ55286634-B398EB5C-3162-45F5-BB5C-30A85F24CEA9Q55332339-52C7F822-1030-46F7-9252-ACA86FC80FA3Q55380047-7CE310FF-0E15-49B7-BB46-3DF795C6263EQ55411384-12E104E9-243A-464C-84D5-DCD47FDCCC41Q55649893-2EE17A66-A5D5-4E55-B64D-87E4A14AC4E7Q57628371-6BED85FC-CBA7-4E87-B895-93E982907221
P2860
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Canagliflozin for Primary and ...... diovascular Assessment Study).
@en
Canagliflozin for Primary and ...... esults From the CANVAS Program
@nl
type
label
Canagliflozin for Primary and ...... diovascular Assessment Study).
@en
Canagliflozin for Primary and ...... esults From the CANVAS Program
@nl
prefLabel
Canagliflozin for Primary and ...... diovascular Assessment Study).
@en
Canagliflozin for Primary and ...... esults From the CANVAS Program
@nl
P2093
P2860
P1433
P1476
Canagliflozin for Primary and ...... rdiovascular Assessment Study)
@en
P2093
CANVAS Program Collaborative Group
David R Matthews
Dick de Zeeuw
Elisa Fabbrini
Greg Fulcher
Kenneth W Mahaffey
Mehul Desai
Ngozi Erondu
Vlado Perkovic
P2860
P304
P356
10.1161/CIRCULATIONAHA.117.032038
P407
P577
2017-11-13T00:00:00Z